Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P. Bhatt, Raolat M. Abdulai, Klaus F. Rabe et al.|New England Journal of Medicine|2023Cited by 452
Benralizumab for the Prevention of COPD ExacerbationsGerard J. Criner, Ubaldo J. Martin, Leif Bjermer et al.|New England Journal of Medicine|2019Cited by 329
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 InflammationSurya P. Bhatt, Lacey B. Robinson, Klaus F. Rabe et al.|New England Journal of Medicine|2024Cited by 240
Tiotropium + olodaterol shows clinically meaningful improvements in quality of lifeDave Singh, Leif Bjermer, Gary T. Ferguson et al.|Respiratory Medicine|2015Cited by 174
(untitled)Fernando J. Martínez, Ruth Tal‐Singer, Àlvar Agustí et al.|Research Explorer (The University of Manchester)|0Cited by 130